Inventor · disambiguated record
Frederick Cohen
Also filed as: COHEN FREDERICK · COHEN FREDERICK B
35 granted patents·20 pending applications·575 citations·filing 1979–2024
97Inventor score
Top patents by PatentIndex Score
55 records- 0198US7244851B2Inhibitors of IAPGENENTECH INC·Filed 2005·Granted Jul 17, 2007·141 cites·21 claims
- 0297US11530229B2Cyano cyclobutyl compounds for CBL-B inhibition and uses thereofNURIX THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·12 cites·71 claims
- 0397US11464802B23-substituted piperidine compounds for Cbl-b inhibition, and use thereofNURIX THERAPEUTICS INC·Filed 2020·Granted Oct 11, 2022·14 cites·53 claims
- 0497US11401267B2Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereofNURIX THERAPEUTICS INC·Filed 2020·Granted Aug 2, 2022·11 cites·32 claims
- 0596US4293323AWaste heat energy recovery systemCOHEN FREDERICK·Filed 1979·Granted Oct 6, 1981·115 cites·6 claims
- 0695US7345081B2Azabicyclo-octane inhibitors of IAPGENENTECH INC·Filed 2005·Granted Mar 18, 2008·62 cites·20 claims
- 0795USD504173SCombined ceiling fan housing and light kitAIR COOL IND CO LTD·Filed 2003·Granted Apr 19, 2005·64 cites·1 claims
- 0894US11951133B23-substituted piperidine compounds for Cbl-b inhibition, and use thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Apr 9, 2024·2 cites·36 claims
- 0992US12485144B23-substituted piperidine compounds for Cbl-b inhibition, and use thereofNURIX THERAPEUTICS INC·Filed 2024·Granted Dec 2, 2025·1 cites·40 claims
- 1092US12049471B2Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Jul 30, 2024·1 cites·16 claims
- 1191US9403758B2Antibacterial agentsACHAOGEN INC·Filed 2014·Granted Aug 2, 2016·8 cites·18 claims
- 1290US12234230B2Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Feb 25, 2025·1 cites·5 claims
- 1390US7399869B2Fibroblast activation protein inhibitor compounds and methodsGENENTECH INC·Filed 2006·Granted Jul 15, 2008·23 cites·21 claims
- 1489US11096982B2Inhibitors of IAPGENENTECH INC·Filed 2019·Granted Aug 24, 2021·2 cites·30 claims
- 1588US8163763B2Pyrimidine compounds, compositions and methods of useBERGERON PHILIPPE·Filed 2009·Granted Apr 24, 2012·28 cites·33 claims
- 1686US8716236B2Inhibitors of IAPGENENTECH INC·Filed 2013·Granted May 6, 2014·5 cites·8 claims
- 1786US7723330B2Heterobicyclic pyrazole compounds and methods of useARRAY BIOPHARMA INC·Filed 2007·Granted May 25, 2010·11 cites·58 claims
- 1885US9868720B2C-linked heterocycloaklyl substituted pyrimidines and their usesGENENTECH INC·Filed 2015·Granted Jan 16, 2018·6 cites·20 claims
- 1985US9586991B2Inhibitors of IAPGENENTECH INC·Filed 2015·Granted Mar 7, 2017·3 cites·10 claims
- 2085US8119654B2Indenoisoquinolinone analogs and methods of use thereofJAGTAP PRAKASH·Filed 2008·Granted Feb 21, 2012·13 cites·43 claims
- 2185US8110568B2Inhibitors of IAPCOHEN FREDERICK·Filed 2010·Granted Feb 7, 2012·7 cites·4 claims
- 2283US9238675B2Inhibitors of IAPGENENTECH INC·Filed 2014·Granted Jan 19, 2016·3 cites·18 claims
- 2382US8095492B2Method and/or system for providing and/or analyzing influence strategiesCOHEN FREDERICK B·Filed 2006·Granted Jan 10, 2012·12 cites·25 claims
- 2481US2025136590A1Substituted benzyl-triazole compounds for cbl-b inhibition, and further uses thereofNURIX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2580US2024409555A1Cyano cyclobutyl compounds for cbl-b inhibition and uses thereofNURIX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2679US11963994B2Inhibitors of IAPGENENTECH INC·Filed 2021·Granted Apr 23, 2024·0 cites·10 claims
- 2776US8980837B2Inhibitors of IAPCOHEN FREDERICK·Filed 2012·Granted Mar 17, 2015·2 cites·16 claims
- 2874US8609845B2Pyrrolidine inhibitors of IAPCOHEN FREDERICK·Filed 2009·Granted Dec 17, 2013·1 cites·13 claims
- 2973US2024400587A1Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereofNURIX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3072US11023901B2Method and/or system for providing and/or analyzing and/or presenting decision strategiesCOHEN FREDERICK B·Filed 2008·Granted Jun 1, 2021·5 cites·20 claims
- 3172US9399636B2Substituted dipyridylamines and uses thereofGENENTECH INC·Filed 2014·Granted Jul 26, 2016·2 cites·17 claims
- 3271US8907092B2Inhibitors of IAPFLYGARE JOHN A·Filed 2008·Granted Dec 9, 2014·3 cites·12 claims
- 3369US11741481B2Method and/or system for providing and/or analyzing and/or presenting decision strategiesMAN ANALYTICS INC·Filed 2021·Granted Aug 29, 2023·0 cites·28 claims
- 3468US12091426B2Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Sep 17, 2024·0 cites·29 claims
- 3566US9040706B2Pyrrolidine inhibitors of IAPGENENTECH INC·Filed 2013·Granted May 26, 2015·0 cites·4 claims
- 3666US2009176822A1Pyrrolidine inhibitors of iapGENENTECH INC·Filed 2008·Application pending·0 cites
- 3763US9701622B2Antibacterial agentsACHAOGEN INC·Filed 2016·Granted Jul 11, 2017·0 cites·20 claims
- 3863US2017369426A1Antibacterial agentsACHAOGEN INC·Filed 2017·Application pending·0 cites
- 3961US2017136084A1Inhibitors of iapGENENTECH INC·Filed 2017·Application pending·0 cites
- 4061US2007299052A1Inhibitors of IAPGENENTECH INC·Filed 2007·Application pending·0 cites
- 4160US2006167066A1Pyrrolidine inhibitors of IAPGENENTECH INC·Filed 2005·Application pending·0 cites
- 4258US6739331B1Charcoal dispensing systemFiled 2003·Granted May 25, 2004·10 cites·13 claims
- 4356US2008146808A1Azabicyclo-octane inhibitors of iapGENENTECH INC·Filed 2008·Application pending·0 cites
- 4455US2008280856A1Fibroblast Activation Protein Inhibitor Compounds and MethodsGENENTECH INC·Filed 2008·Application pending·0 cites
- 4551US2010261706A1Substituted tetracyclic 1h-indeno [1,2-b]pyridine-2(5h)-one analogs thereof and uses thereofINOTEK PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 4651US2011046066A1Inhibitors of iapGENENTECH INC·Filed 2009·Application pending·0 cites
- 4751US2022387395A1Urea, amide, and substituted heteroaryl compounds for cbl-b inhibitionNURIX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4850US2022324835A1Inhibitors of cbl-b and methods of use thereofNURIX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4947US2015175530A1Antibacterial agentsACHAOGEN INC·Filed 2014·Application pending·0 cites
- 5045US2014088736A1Consistency Analysis in Control Systems During Normal OperationMAN ANALYTICS·Filed 2013·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Frederick Cohen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →